-
公开(公告)号:WO2007073497A3
公开(公告)日:2008-08-28
申请号:PCT/US2006048925
申请日:2006-12-20
IPC分类号: C07D417/12 , A61K31/506 , A61P9/10 , A61P25/08 , A61P25/14 , A61P25/28
CPC分类号: C07D417/12 , C07D277/28 , C07D277/34 , C07D277/36 , C07D277/46 , C07D277/54 , C07D277/56 , C07D413/04 , C07D417/04 , C07D417/14
摘要: The present invention provides novel calcium channel antagonists, and methods of treating disease sates using the novel antagonists.
摘要翻译: 本发明提供新型钙通道拮抗剂,以及使用新型拮抗剂治疗疾病的方法。
-
公开(公告)号:WO2007056099A3
公开(公告)日:2007-07-12
申请号:PCT/US2006042882
申请日:2006-11-02
申请人: ICAGEN INC , WANG XIAODONG , FULP ALAN , MARRON BRIAN , BEAUDOIN SERGE , SECONI DARRICK , SUTO MARK
发明人: WANG XIAODONG , FULP ALAN , MARRON BRIAN , BEAUDOIN SERGE , SECONI DARRICK , SUTO MARK
IPC分类号: A01N43/40
CPC分类号: C07D277/52 , C07D417/12 , C07D417/14
摘要: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
摘要翻译: 提供了可用于通过电压门控钠通道抑制钠离子通量来治疗疾病的化合物,组合物和方法。 更具体地,本发明提供取代的芳基磺酰胺,包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或周围神经系统疾病,特别是疼痛和慢性疼痛的方法,其通过阻断与起始相关的钠通道或 指示条件复发。 本发明的化合物,组合物和方法特别用于通过电压门控钠通道抑制离子通量来治疗神经性或炎性疼痛。
-
公开(公告)号:WO2007075849A3
公开(公告)日:2007-07-05
申请号:PCT/US2006/048716
申请日:2006-12-20
IPC分类号: A01N55/00 , A61K31/695 , A61K31/65
摘要: The use of novel inhibitors of potassium flux is disclosed for the treatment of inflammatory processes, such as multiple sclerosis, insulin-dependent (type I) diabetes mellitus, rheumatoid arthritis, peripheral neuritis and pulmonary hypertension. The compounds are also of use in treating and preventing stroke. These inhibitors have a high specificity for the IK1 channel and greater stability relative to non-fluorine substituted homologues.
-
公开(公告)号:WO2005121126A1
公开(公告)日:2005-12-22
申请号:PCT/US2005/012525
申请日:2005-04-13
申请人: ICAGEN, INC. , ASTELLAS PHARMA INC. , WANG, Xiaodong , SPEAR, Kerry, Leigh , FULP, Alan, Bradley , SECONI, Darrick , SUZUKI, Takeshi , ISHII, Takahiro , MORITOMO, Ayako
发明人: WANG, Xiaodong , SPEAR, Kerry, Leigh , FULP, Alan, Bradley , SECONI, Darrick , SUZUKI, Takeshi , ISHII, Takahiro , MORITOMO, Ayako
IPC分类号: C07D401/12
CPC分类号: C07D401/14 , C07D213/73 , C07D401/04 , C07D405/04 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D417/14
摘要: The present invention provides a genus of polycyclic pyrazines of formula I (I) that are useful as modulators of potassium ion channels. The modulators of the invention are of use in both therapeutic and diagnostic methods; wherein A and B are independently substituted or unsubstituted 5- or 6-membered heterocycloalkyl, or substituted or unsubstituted 5- or 6- membered heteroaryl, W 1 is formula II (II); W 2 is -CH=, -NH-, -N=, -S-, or -O-; Z 1 is formula III (III) or formula IV (IV); Z 2 is -CH=, -NH-, -N=, -S-, or -O-; Y is a bond, -CH=N-NH-, -NH-CH 2 -, or -NR 5 -; s and t are independently integers from 1 to 4; R 1 , R 2A , R 2B and R 3 are independently or unsubstituted alkyle, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted 3- to 7- membered cycloalkyl,, substituted or unsubstituted 5- to 7-membered heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; and R 5 is H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted 3- to 7- membered cycloalkyl,, substituted or unsubstituted 5- to 7-membered heterocycloalkyl, substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl; wherein if s is greater than one, then each R 1 is optionally different; wherein if t is greater than on, then each R 3 is optionally different; wherein two R 1 groups are optionally joined together with the atoms to which they are attached to form a substituted or unsubstituted ring; and wherein two R 3 groups are optionally joined together with the atoms to which they are attached to form a susbtituted or unsubstituted ring.
摘要翻译: 本发明提供了可用作钾离子通道调节剂的式I(I)的多环吡嗪属。 本发明的调节剂可用于治疗和诊断方法; 其中A和B独立地为取代或未取代的5-或6-元杂环烷基,或取代或未取代的5-或6-元杂芳基,W 1为式II(II); W 2是-CH =,-NH-,-N =,-S-或-O-; Z 1是式III(III)或式IV(IV); Z 2是-CH =,-NH-,-N =,-S-或-O-; Y是键,-CH = N-NH-,-NH-CH 2 - 或-NR 5 - ; s和t独立地为1至4的整数; R 1,R 2A,R 2B和R 3独立地是未取代的烷基,取代或未取代的烷基,取代或未取代的杂烷基,取代或未取代的3-至7-元环烷基,取代或未取代的 5-至7-元杂环烷基,取代或未取代的芳基或取代或未取代的杂芳基; 并且R 5是H,取代或未取代的烷基,取代或未取代的杂烷基,取代或未取代的3-至7-元环烷基,取代或未取代的5-至7-元杂环烷基,取代或未取代的芳基或取代或未取代的杂芳基 ; 其中如果s大于1,则每个R 1任选地不同; 其中如果t大于on,则每个R 3任选地不同; 其中两个R 1基团任选地与它们所连接的原子连接在一起形成取代或未取代的环; 并且其中两个R 3基团任选地与它们所连接的原子连接在一起以形成未取代或未取代的环。
-
公开(公告)号:WO2005025293A3
公开(公告)日:2005-06-16
申请号:PCT/US2004029868
申请日:2004-09-10
IPC分类号: C07D239/92 , C07D285/24 , C07D401/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D498/04 , C07D513/04 , A61K31/497 , A01N43/54 , A61K31/517 , C07D401/00 , C07D403/00 , C07D413/00 , C07D417/00 , C07D419/00
CPC分类号: C04B35/632 , C07D239/92 , C07D285/24 , C07D401/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D513/04
摘要: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides quinazolinone, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders (e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, trigeminal neuralgia, spasticity, mood disorders, brain tumors, psychotic disorders, myokymia, seizures, epilepsy, hearing and vision loss, Alzheimer's disease, age-related memory loss, learning deficiencies, anxiety and motor neuron diseases, maintaining bladder control or treating urinary incontinence) and as neuroprotective agents (e.g., to prevent stroke and the like) by modulating potassium channels associated with the onset or recurrence of the indicated conditions. .
摘要翻译: 提供了通过电压依赖钾通道调节钾离子通量可用于治疗疾病的化合物,组合物和方法。 更具体地,本发明提供可用于治疗中枢性或周围神经系统疾病(例如偏头痛,共济失调,帕金森病,双相情感障碍,三叉神经痛,痉挛状态,情绪障碍,脑肿瘤,精神病性障碍)的喹唑啉酮,组合物和方法 ,肌抑制,癫痫发作,癫痫,听力和视力丧失,阿尔茨海默病,年龄相关的记忆丧失,学习缺陷,焦虑和运动神经元疾病,维持膀胱控制或治疗尿失禁)和作为神经保护剂(例如,为了预防中风和 通过调节与指定条件的发作或复发相关的钾通道。 。
-
公开(公告)号:WO2005025293A2
公开(公告)日:2005-03-24
申请号:PCT/US2004/029868
申请日:2004-09-10
申请人: ICAGEN, INC. , MCNAUGHTON-SMITH, Grant, Andrew , AMATO, George, Salvatore , THOMAS, James, Barnwell, Jr.
IPC分类号: C07D239/92 , C07D285/24 , C07D401/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D498/04 , C07D513/04
CPC分类号: C04B35/632 , C07D239/92 , C07D285/24 , C07D401/12 , C07D409/12 , C07D413/12 , C07D471/04 , C07D487/04 , C07D513/04
摘要: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the modulation of potassium ion flux through voltage-dependent potassium channels. More particularly, the invention provides quinazolinone, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders (e.g., migraine, ataxia, Parkinson's disease, bipolar disorders, trigeminal neuralgia, spasticity, mood disorders, brain tumors, psychotic disorders, myokymia, seizures, epilepsy, hearing and vision loss, Alzheimer's disease, age-related memory loss, learning deficiencies, anxiety and motor neuron diseases, maintaining bladder control or treating urinary incontinence) and as neuroprotective agents (e.g., to prevent stroke and the like) by modulating potassium channels associated with the onset or recurrence of the indicated conditions. .
摘要翻译: 提供了用于通过调节通过电压依赖性钾通道的钾离子通量来治疗疾病的化合物,组合物和方法。 更具体地说,本发明提供了可用于治疗中枢或周围神经系统疾病(例如偏头痛,共济失调,帕金森氏病,双相性精神障碍,三叉神经痛,痉挛状态,心境障碍,脑肿瘤,精神病性障碍等的喹唑啉酮,组合物和方法 ,失眠,癫痫发作,癫痫,听力和视力丧失,阿尔茨海默病,与年龄有关的记忆丧失,学习缺陷,焦虑和运动神经元疾病,维持膀胱控制或治疗尿失禁)和作为神经保护剂(例如预防中风和 类似)通过调节与指示病症的发作或复发有关的钾通道。 p>
-
公开(公告)号:WO02066955A8
公开(公告)日:2003-12-31
申请号:PCT/US0205707
申请日:2002-02-13
CPC分类号: C40B30/02 , G01N33/6872 , G01N2500/00 , G01N2500/04
摘要: A method for screening compounds for biological activity is disclosed. The method may include selecting a test set of compounds and selecting a training set of compounds. An assay is performed on the training set of compounds and training set data are formed. This data are entered into a digital computer, and an analytical model is formed. A subset of compounds is identified using the analytical model.
摘要翻译: 公开了用于筛选生物活性化合物的方法。 该方法可以包括选择一组化合物并选择一组化合物。 对化合物的训练集进行测定,形成训练集数据。 该数据输入到数字计算机中,形成分析模型。 使用分析模型识别化合物的一个子集。
-
公开(公告)号:WO03037890A3
公开(公告)日:2003-08-21
申请号:PCT/US0235173
申请日:2002-11-01
IPC分类号: A61K31/00 , A61K31/4439 , A61P25/04 , C07D401/04 , C07D401/14 , C07D405/14 , C07D413/14
CPC分类号: C07D401/04 , A61K31/00 , A61K31/4439 , C07D401/14 , C07D405/14 , C07D413/14
摘要: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides substituted piperidines, and compositions containing these compounds. Also provided are methods using the compounds of the invention for the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.
摘要翻译: 提供了通过抑制钠离子通过电压依赖钠通道来治疗疾病的化合物,组合物和方法。 更具体地说,本发明提供取代的哌啶和含有这些化合物的组合物。 还提供了使用本发明化合物治疗中枢性或周围神经系统疾病,特别是疼痛和慢性疼痛的方法,其通过阻断与所述病症的发作或复发有关的钠通道。 本发明的化合物,组合物和方法特别用于通过包含PN3亚基的通道抑制离子通量来治疗神经性或炎性疼痛。
-
公开(公告)号:WO2003047739A3
公开(公告)日:2003-06-12
申请号:PCT/US2002/038429
申请日:2002-12-03
IPC分类号: G01N33/48
摘要: Methods and compositions for enhancing chemical libraries with biologically active molecules are taught. Relevant physicochemical descriptors that correlate with biological activity are calculated and selected. Database descriptors are identified using the physicochemical descriptors and an electronic database can be formed.
-
公开(公告)号:WO2003037900A2
公开(公告)日:2003-05-08
申请号:PCT/US2002/035171
申请日:2002-11-01
IPC分类号: C07D487/04
CPC分类号: C07D487/04 , A61K31/519
摘要: Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides pyrazolopyrimidines, compositions and methods that are useful in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.
摘要翻译: 提供了通过抑制钠离子通过电压依赖钠通道来治疗疾病的化合物,组合物和方法。 更具体地,本发明提供了可用于治疗中枢或周围神经系统疾病,特别是疼痛和慢性疼痛的吡唑并嘧啶类,组合物和方法,其通过阻断与所述病症的发作或复发有关的钠通道。 本发明的化合物,组合物和方法特别用于通过包含PN3亚基的通道抑制离子通量来治疗神经性或炎性疼痛。
-
-
-
-
-
-
-
-
-